- Funding accelerates Ultromics’ work to close one of medicine’s most pervasive health-equity gaps: heart failure with preserved ejection fraction (HFpEF), a condition that affects millions of women worldwide yet often goes unrecognized
- Built and validated on diverse, outcomes-based data, Ultromics’ AI turns a routine heart ultrasound into an objective diagnostic tool, helping clinicians identify early heart failure before symptoms are dismissed or missed
OXFORD, England, Dec. 17, 2025 /PRNewswire/ — Ultromics, a pioneer in AI-driven cardiology solutions, today announced an investment from the American Heart Association’s Go Red for Women Venture Fund, a fund within American Heart Association Ventures (the venture capital program of the American Heart Association). The funding accelerates Ultromics’ mission to make early identification of heart failure…
